{"id":904060,"date":"2025-11-03T08:39:40","date_gmt":"2025-11-03T13:39:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/"},"modified":"2025-11-03T08:39:40","modified_gmt":"2025-11-03T13:39:40","slug":"cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/","title":{"rendered":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit"},"content":{"rendered":"

<\/p>\n

Cybin to Participate at the 2025 Milken Institute Future of Health Summit<\/b><\/p>\n

– Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 –<\/i><\/p>\n

TORONTO–(BUSINESS WIRE<\/a>)–Cybin Inc.<\/a> (NYSE American:CYBN) (Cboe CA:CYBN) (\u201dCybin\u201d or the \u201cCompany\u201d), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that Amir Inamdar, Cybin\u2019s Chief Medical Officer, will participate in a panel at the 2025 Milken Institute Future of Health Summit, taking place November 4-6, 2025, in Washington, D.C. The panel details are as follows:<\/p>\n

Panel title:<\/b>Reimagining Mental Health: Innovation at the Intersection of Care and Technology
\n<\/a>
Date: <\/b>Wednesday, November 5, 2025
\n
Time:<\/b> 2:00 \u2013 3:00 PM ET<\/p>\n

\nTo access the live panel discussion, please click here<\/a>. The archived webcast will also be available on the Company\u2019s investor relations website on the Events & Presentations<\/a> page.<\/p>\n

About Cybin<\/b><\/p>\n

\nCybin is a breakthrough Phase 3 clinical-stage neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet need for people who suffer from mental health conditions.<\/p>\n

\nWith promising class leading data, Cybin is working to change the mental health treatment landscape through the introduction of novel drugs that provide effective and durable results for patients. The Company is currently developing CYB003, a proprietary deuterated psilocin analog, in Phase 3 studies for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration and CYB004, a proprietary deuterated N, N-dimethyltryptamine molecule in a Phase 2 study for generalized anxiety disorder. The Company also has a research pipeline of investigational, 5-HT-receptor focused compounds.<\/p>\n

\nFounded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, and Ireland.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251103373566\/en\/<\/a><\/span><\/p>\n

Investor Contact:
\n<\/b>
Josh Barer
\n
astr partners
\n
Managing Director
\n
(908) 578-6478
\n
josh.barer@astrpartners.com<\/a><\/p>\n

\nGeorge Tziras
\n
Chief Business Officer
\n
Cybin Inc.
\n
1-866-292-4601
\n
irteam@cybin.com<\/a> \u2013 or \u2013 media@cybin.com<\/a><\/p>\n

KEYWORDS:<\/b> District of Columbia United States North America Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Alternative Medicine Mental Health Health Neurology Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Cybin to Participate at the 2025 Milken Institute Future of Health Summit – Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 – TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (\u201dCybin\u201d or the \u201cCompany\u201d), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that Amir Inamdar, Cybin\u2019s Chief Medical Officer, will participate in a panel at the 2025 Milken Institute Future of Health Summit, taking place November 4-6, 2025, in Washington, D.C. The panel details are as follows: Panel title:Reimagining Mental Health: Innovation at the Intersection of Care and Technology Date: Wednesday, November 5, 2025 Time: 2:00 \u2013 3:00 PM … <\/p>\n

Continue reading “Cybin to Participate at the 2025 Milken Institute Future of Health Summit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904060","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCybin to Participate at the 2025 Milken Institute Future of Health Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cybin to Participate at the 2025 Milken Institute Future of Health Summit – Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 – TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (\u201dCybin\u201d or the \u201cCompany\u201d), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that Amir Inamdar, Cybin\u2019s Chief Medical Officer, will participate in a panel at the 2025 Milken Institute Future of Health Summit, taking place November 4-6, 2025, in Washington, D.C. The panel details are as follows: Panel title:Reimagining Mental Health: Innovation at the Intersection of Care and Technology Date: Wednesday, November 5, 2025 Time: 2:00 \u2013 3:00 PM … Continue reading "Cybin to Participate at the 2025 Milken Institute Future of Health Summit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T13:39:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cybin to Participate at the 2025 Milken Institute Future of Health Summit\",\"datePublished\":\"2025-11-03T13:39:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/\"},\"wordCount\":366,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/\",\"name\":\"Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-11-03T13:39:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cybin to Participate at the 2025 Milken Institute Future of Health Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/","og_locale":"en_US","og_type":"article","og_title":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Market Newsdesk","og_description":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit – Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 – TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (\u201dCybin\u201d or the \u201cCompany\u201d), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative delivery systems, today announced that Amir Inamdar, Cybin\u2019s Chief Medical Officer, will participate in a panel at the 2025 Milken Institute Future of Health Summit, taking place November 4-6, 2025, in Washington, D.C. The panel details are as follows: Panel title:Reimagining Mental Health: Innovation at the Intersection of Care and Technology Date: Wednesday, November 5, 2025 Time: 2:00 \u2013 3:00 PM … Continue reading \"Cybin to Participate at the 2025 Milken Institute Future of Health Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T13:39:40+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit","datePublished":"2025-11-03T13:39:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/"},"wordCount":366,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/","name":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-11-03T13:39:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251103373566r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cybin-to-participate-at-the-2025-milken-institute-future-of-health-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cybin to Participate at the 2025 Milken Institute Future of Health Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904060"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904060\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}